|
Miltenyi Biotec
cd34 microbead kit, human Cd34 Microbead Kit, Human, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cd34 microbead kit, human/product/Miltenyi Biotec Average 97 stars, based on 1 article reviews
cd34 microbead kit, human - by Bioz Stars,
2026-04
97/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
cd34 microbead kit ultrapure, human Cd34 Microbead Kit Ultrapure, Human, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cd34 microbead kit ultrapure, human/product/Miltenyi Biotec Average 96 stars, based on 1 article reviews
cd34 microbead kit ultrapure, human - by Bioz Stars,
2026-04
96/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
minimacs cd34 isolation kit system Minimacs Cd34 Isolation Kit System, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/minimacs cd34 isolation kit system/product/Miltenyi Biotec Average 94 stars, based on 1 article reviews
minimacs cd34 isolation kit system - by Bioz Stars,
2026-04
94/100 stars
|
Buy from Supplier |
|
STEMCELL Technologies Inc
easysep human cord blood cd34 positive selection kit Easysep Human Cord Blood Cd34 Positive Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/easysep human cord blood cd34 positive selection kit/product/STEMCELL Technologies Inc Average 90 stars, based on 1 article reviews
easysep human cord blood cd34 positive selection kit - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
cd34 cell isolation kit Cd34 Cell Isolation Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cd34 cell isolation kit/product/Miltenyi Biotec Average 95 stars, based on 1 article reviews
cd34 cell isolation kit - by Bioz Stars,
2026-04
95/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
direct cd34 progenitor isolation kit ![]() Direct Cd34 Progenitor Isolation Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/direct cd34 progenitor isolation kit/product/Miltenyi Biotec Average 96 stars, based on 1 article reviews
direct cd34 progenitor isolation kit - by Bioz Stars,
2026-04
96/100 stars
|
Buy from Supplier |
|
Danaher Inc
stemkit cd34 kit ![]() Stemkit Cd34 Kit, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/stemkit cd34 kit/product/Danaher Inc Average 86 stars, based on 1 article reviews
stemkit cd34 kit - by Bioz Stars,
2026-04
86/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
cd34 multisort kit ![]() Cd34 Multisort Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cd34 multisort kit/product/Miltenyi Biotec Average 93 stars, based on 1 article reviews
cd34 multisort kit - by Bioz Stars,
2026-04
93/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
human cd34 ![]() Human Cd34, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human cd34/product/Miltenyi Biotec Average 97 stars, based on 1 article reviews
human cd34 - by Bioz Stars,
2026-04
97/100 stars
|
Buy from Supplier |
|
Thermo Fisher
elisa assay kit (ebioscience) ![]() Elisa Assay Kit (Ebioscience), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/elisa assay kit (ebioscience)/product/Thermo Fisher Average 90 stars, based on 1 article reviews
elisa assay kit (ebioscience) - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
cd34 microbead kit ![]() Cd34 Microbead Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cd34 microbead kit/product/Miltenyi Biotec Average 96 stars, based on 1 article reviews
cd34 microbead kit - by Bioz Stars,
2026-04
96/100 stars
|
Buy from Supplier |
|
Thermo Fisher
dynabeads cd34 positive isolation kit ![]() Dynabeads Cd34 Positive Isolation Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/dynabeads cd34 positive isolation kit/product/Thermo Fisher Average 90 stars, based on 1 article reviews
dynabeads cd34 positive isolation kit - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Cell reports
Article Title: Identification of the global miR-130a targetome reveals a role for TBL1XR1 in hematopoietic stem cell self-renewal and t(8;21) AML.
doi: 10.1016/j.celrep.2022.110481
Figure Lengend Snippet: Figure 2. Enforced expression of miR-130a expands HSCs by forcing them into cell cycle (A) Representative flow plots of HSPC populations from control and miR-130a OE xenografts at 12 weeks. (B) Proportion of CD34+CD38 compartment and frequency of LT-HSC, ST-HSC, and MLP (multi-lymphoid progenitor) cell populations (n = 4, each replicate contains pooled RF and BM from 2 to 4 individual mice). (C) Proportion of CD34+CD38+ compartment and frequency of CMP (common myeloid progenitor), MEP (megakaryocyte-erythroid progenitor), and GMP (granulocyte-macrophage progenitor) cell populations (n = 4, each replicate contains pooled RF and BM from 2 to 4 individual mice). (D) Secondary transplantation of CD45+mO+ from 12 week NSG mice at limiting dilution doses. Frequency of HSCs was evaluated from the engraftment in secondary mice (>0.05% CD45+mO+ cells in BM, n = 19–31 mice from two independent experiments). (E) Normalized enrichment score (NES) of the gene sets significantly different between miR-130a OE and control-transduced HSCPs (n = 3). (F) GSEA plots of HSC cell-cycle-primed gene sets and MYC targets in the transcriptome profile following miR-130a OE in CD34+ HSPCs. (G) Cell-cycle analysis of LT-HSCs, ST-HSCs, and CD34+CD38+ cells transduced with miR-130a or control lentiviruses (n = 3). (B and C) Unpaired t test, all error bars indicate ±SEM, *p < 0.05.
Article Snippet: Quantitative RT-PCR for expression levels of miR-130a in CBF AML Peripheral blood samples from t(8;21) and inv(16) patients (Table S5) were thawed as described and CD34+ blasts were enriched with
Techniques: Expressing, Control, Transplantation Assay, Cell Cycle Assay, Transduction
Journal: Cell reports
Article Title: Identification of the global miR-130a targetome reveals a role for TBL1XR1 in hematopoietic stem cell self-renewal and t(8;21) AML.
doi: 10.1016/j.celrep.2022.110481
Figure Lengend Snippet: Figure 3. Mass spectrometry and chimeric AGO2 eCLIP identify miR-130a targetome in human HSPCs (A) Heatmap of downregulated pathways and proteins following miR-130a OE in CD34+ CB cells; Wilcoxon one-sided test, n = 3, p < 0.05. (B) List of miR-130a downregulated proteins that are predicted TarBase and mirDIP targets, limma t test. (C) Western blot showing repression of miR-130a targets. (D) Enrichment map showing gene sets containing miR-130a targets listed in (B); node size is proportional to NES; Wilcoxon one-sided test, p < 0.05. (E) GSEA plots of miR-130a targets from chimeric AGO2 eCLIP in proteome profile following miR-130a OE in CD34+ HSPCs. (F) Genome browser tracks from chimeric AGO2 eCLIP-seq in CD34+ HSPCs. (G) Enrichment map of miR-130a targets from chimeric AGO2 eCLIP in downregulated protein sets following miR-130a OE; false discovery rate (FDR) < 0.05, node size is proportional to NES, Wilcoxon one-sided test; p < 0.05.
Article Snippet: Quantitative RT-PCR for expression levels of miR-130a in CBF AML Peripheral blood samples from t(8;21) and inv(16) patients (Table S5) were thawed as described and CD34+ blasts were enriched with
Techniques: Mass Spectrometry, Western Blot
Journal: Cell reports
Article Title: Identification of the global miR-130a targetome reveals a role for TBL1XR1 in hematopoietic stem cell self-renewal and t(8;21) AML.
doi: 10.1016/j.celrep.2022.110481
Figure Lengend Snippet: Figure 4. Repression of TBL1XR1 impairs B lymphoid differentiation and expands LT-HSC (A) Western blot showing TBL1XR1 protein levels in xenografts. (B) Human CD45+ chimerism in the right femur (RF) and bone marrow (BM) at 24 weeks post-transplantation (n = 2 biological experiments, 6–8 mice/experimental group). (C) Fold change in BFP+CD45+ cells in RF and BM at 24 weeks post-transplantation compared with input levels. (D) Lineage distribution of BFP+ xenografts. (E) Flow cytometry plots of HSPC populations, flow plots are representative of 3 samples overlaid together. (F) Distribution of BFP+CD34+CD38 cell populations from 24 week xenografts (n = 5, each replicate contains pooled RF from 2 to 4 individual mice), unpaired t test, *p < 0.05. (G) Secondary transplantation of CD45+BFP+ from 24 week NSG mice at limiting dilution doses. Frequency of HSC was evaluated from the engraftment in NSG- GF secondary mice (>0.05% CD45+BFP+cell in BM, n = 11–16 mice/experimental group). (H) Enrichment map of upregulated (red nodes) and downregulated (blue nodes) pathways following TBL1XR1 KD intersected with miR-130a targets from eCLIP, hypergeometric t test, p < 0.05. (I) GSEA plots of proliferative and quiescence genes in transcriptome profile following TBL1XR1 KD. (J) Western blot showing protein levels of NCoR1 and TBL1XR1 following TBL1XR1 KD in CD34+ CB cells. (K) GSEA plots of genes upregulated and downregulated by RA in the transcriptome profile following TBL1XR1 KD. (B–D) Unpaired Mann-Whitney U test, all error bars indicate ±SEM, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Article Snippet: Quantitative RT-PCR for expression levels of miR-130a in CBF AML Peripheral blood samples from t(8;21) and inv(16) patients (Table S5) were thawed as described and CD34+ blasts were enriched with
Techniques: Western Blot, Transplantation Assay, Flow Cytometry, MANN-WHITNEY
Journal: Cell reports
Article Title: Identification of the global miR-130a targetome reveals a role for TBL1XR1 in hematopoietic stem cell self-renewal and t(8;21) AML.
doi: 10.1016/j.celrep.2022.110481
Figure Lengend Snippet: Figure 5. Loss of function of miR-130a and TBL1XR1 OE induces differentiation of t(8;21) AML (A) Clustering of TCGA AMLs into four groups based on scRNA-seq data (n = 173). (B) Expression of miR-130a in AML subtypes from the TCGA dataset (n = 170). (C) Kaplan-Meier curve showing correlation between miR-130a expression and CBF AML patient survival (n = 48). (D) qRT-PCR showing expression levels of miR-130a in CD34+ blasts from t(8;21) AML compared with healthy controls (n = 20) and CD34 cells from the same patient samples (n = 24).
Article Snippet: Quantitative RT-PCR for expression levels of miR-130a in CBF AML Peripheral blood samples from t(8;21) and inv(16) patients (Table S5) were thawed as described and CD34+ blasts were enriched with
Techniques: Expressing, Quantitative RT-PCR
Journal: Nucleic Acids Research
Article Title: A regulatory circuit comprising GATA1/2 switch and microRNA-27a/24 promotes erythropoiesis
doi: 10.1093/nar/gkt848
Figure Lengend Snippet: GATA-1 was located on the upstream of miR-23a∼27a∼24-2 cluster and activated its expression during erythropoiesis. ( A ) Q-PCR analysis of the primary transcript of the miR-23a∼27a∼24-2 cluster in K562s undergoing erythroid differentiation caused by hemin treatment for 0, 24, 48 and 72 h. ( B ) Q-PCR analysis of the mature transcripts of miR-27a, miR-24 and miR-23a in K562s undergoing erythroid differentiation caused by hemin treatment for 0, 24, 48 and 72 h. ( C ) Northern blot analysis of miR-27a, miR-24 and miR-23a in K562s undergoing erythroid differentiation. U6 snRNA was used as a loading control. ( D ) Q-PCR analysis of mature miR-27a and miR-24 expression in CD34+ HPCs undergoing day 4, 7, 11, 15 and 18 of E culture. ( E ) Representation of the human −603 bp miR-23a∼27a∼24 cluster promoter fragments. ( F ) ChIP-PCR and ChIP-qPCR analysis of the GATA-1 hit on the −557 site at the miR-23a∼27a∼24 cluster promoter in K562s. ChIP-q-PCR results are shown as fold enrichment compared with input. Error bars represent the standard deviation obtained from three independent experiments. ** P < 0.01. ( G ) Immunoblot analysis of GATA-1 expression in K562s treated with siRNAs specific to GATA-1 (si_GATA-1) for 48 h or K562s transfected with a construct overexpressing GATA-1 (over_GATA-1) for 48 h, respectively. ( H ) Q-PCR analysis of Pri-27a∼24, mature miR-27a and miR-24 expression in K562s treated as described in (G). ( I ) Immunoblot analysis of GATA-1 expression in K562s undergoing erythroid differentiation. ( J ) ChIP-PCR and ChIP-q-PCR analysis of GATA-1 and pol II occupancy at the −557 site in hemin-treated K562s at 0 and 48 h. ChIP-q-PCR results are shown as fold enrichment compared with input. Error bars represent the standard deviation obtained from three independent experiments. * P < 0.05. ( K ) Functional activity of GATA-1 on the wild-type GATA site (WT) or mutant site (MUT) of the miR-23a∼27a∼24 promoter in a luciferase reporter analysis. Error bars represent the standard deviation obtained from three independent experiments. * P < 0.05.
Article Snippet: CD34+ cells were enriched from mononuclear cells through positive immunomagnetic selection (
Techniques: Expressing, Northern Blot, Control, ChIP-qPCR, Standard Deviation, Western Blot, Transfection, Construct, Functional Assay, Activity Assay, Mutagenesis, Luciferase
Journal: Nucleic Acids Research
Article Title: A regulatory circuit comprising GATA1/2 switch and microRNA-27a/24 promotes erythropoiesis
doi: 10.1093/nar/gkt848
Figure Lengend Snippet: MiR-27a and miR-24 promoted erythroid differentiation in CD34+ HPCs. ( A ) Monitoring of the GFP + population (left panel) and the CD235a stained GFP + fraction (medium panel) of Lenti-miRNA-transduced CD34+ HPCs on day 15 of E culture. The morphology (May-Grunwald Giemsa staining) of CD34+ HPCs derivatives on day 15 is shown in the right panel. A 400X magnification of a representative field is shown. ( B ) Detection of the erythroid differentiation degree of CD34+ HPCs transduced with Lenti-27a, Lenti-24 or Lenti-GFP in E culture at the indicated time. Percentages of basophilic (Bas), polychromatophilic (Pol), orthochromatic (Ort) erythroblasts and erythrocytes (Ery) were determined by May-Grunwald/Giemsa staining of cytospin preparations. ( C ) Q-PCR analysis of gamma-globin mRNA expression in CD34+ HPCs transduced with Lenti-27a, Lenti-24 or Lenti-GFP in E culture at the indicated time. ( D ) A comparison of the erythroid colony-forming capacity (CFU-E, BFU-E) of CD34+ HPCs transduced with Lenti-miRNAs. Error bars represent the standard deviation obtained from three independent experiments. * P < 0.05; ** P < 0.01. ( E ) FACS monitoring of CD34+ HPCs transduced with Zip-miRNA or Zip-GFP as described in (A). ( F ) Detection of the erythroid differentiation degree of CD34+ HPCs transduced with Zip-27a, Zip-24 or Zip-GFP as described in (B). ( G ) Detection of gamma-globin mRNA level in CD34+ HPCs transduced with Zip-miRNA. ( H ) Colony-forming assay of CD34+ HPCs transduced with Zip-miRNA as described in (D).
Article Snippet: CD34+ cells were enriched from mononuclear cells through positive immunomagnetic selection (
Techniques: Staining, Transduction, Expressing, Comparison, Standard Deviation
Journal: Nucleic Acids Research
Article Title: A regulatory circuit comprising GATA1/2 switch and microRNA-27a/24 promotes erythropoiesis
doi: 10.1093/nar/gkt848
Figure Lengend Snippet: GATA-2 was post-transcriptionally regulated by miR-27a and miR-24 during erythropoiesis. ( A ) A computer prediction of conserved and mutated binding sites within the 3′ UTR of GATA-2 mRNA for miR-27a and miR-24. ( B ) Relative luciferase activity of the indicated GATA-2 reporter constructs. Error bars represent the standard deviation obtained from three independent experiments. * P < 0.05. ( C ) Immunoblot analysis of GATA-2 in K562s transfected with scramble or miRNA mimics (miR-27a, miR-24) or inhibitors (Anti-27a, Anti-24). ( D ) Immunoblot analysis of GATA-2 in CD34+ HPCs transduced with Lenti-GFP control and lentivirus expressing miR-27a or miR-24 (Lenti-27a or Lenti-24). ( E, F ) ‘Rescue’ assays for miRNAs and GATA-2 during erythroid differentiation. Immunoblot analysis of GATA-2 in K562s treated with scramble or Anti-27a/24 (E) for 24 h. These cells were subsequently treated for another 24 h with control siRNAs or siRNAs specific to GATA-2 and were then treated with hemin treatment for 0, 48 and 72 h. (F) FACS analysis of K562s stained for CD71 and CD235a expression after 48 h of hemin induction as described earlier in the text.
Article Snippet: CD34+ cells were enriched from mononuclear cells through positive immunomagnetic selection (
Techniques: Binding Assay, Luciferase, Activity Assay, Construct, Standard Deviation, Western Blot, Transfection, Transduction, Control, Expressing, Staining
Journal: Nucleic Acids Research
Article Title: A regulatory circuit comprising GATA1/2 switch and microRNA-27a/24 promotes erythropoiesis
doi: 10.1093/nar/gkt848
Figure Lengend Snippet: The GATA switch regulated miR-27a and miR-24 expression. ( A ) ChIP-PCR and ChIP-q-PCR analysis of GATA-1, GATA-2 and Pol II occupancy at the −557 site in hemin-treated K562s at 0 and 48 h. ChIP-q-PCR results are shown as fold enrichment compared with input. Error bars represent the standard deviation obtained from three independent experiments. * P < 0.05; ** P < 0.01. ( B ) Immunoblot analysis of GATA-1 and GATA-2 expression in K562s undergoing erythroid differentiation for 0, 24, 48 and 72 h. ( C ) Functional activity of GATA-1 and GATA-2 on the wild-type GATA site (WT) or mutant site (MUT) of the miR-23a∼27a∼24 promoter in a luciferase reporter analysis. Error bars represent the standard deviation obtained from three independent experiments. * P < 0.05. ( D ) Immunoblot analysis of GATA-2 in K562s treated with siRNAs specific to GATA-2 (si_GATA-2) for 48 h or K562s transfected with a construct overexpressing GATA-2 (over_GATA-2) for 48 h, respectively. ( E ) Q-PCR analysis of Pri-27a∼24, mature miR-27a and miR-24 expression in K562s treated as described in (D). ( F ) ChIP-PCR analysis of GATA-1 and GATA-2 occupancy at the −557 site in K562s transfected with control siRNAs or siRNAs specific to GATA-1/GATA-2 or K562s transfected with empty pcDNA3.1 vectors or pcDNA3.1_GATA-1/GATA-2. ( G ) ChIP-PCR and ChIP-q-PCR analysis of GATA-1 and GATA-2 occupancy at the −557 site in CD34+ HPCs of E culture. ( H ) Q-PCR analysis of Pri-27a-24 abundance in CD34+ HPCs of E culture (Top panel). Error bars represent the standard deviation obtained from three independent experiments. An immunoblot analysis of GATA-1 and GATA-2 expression in CD34+ HPCs of E culture (Bottom panel). ( I ) Q-PCR (left panel) and immunoblot (right panel) analysis of GATA-1 and GATA-2 expression in CD34+ HPCs transduced with lentivirus-expressing siRNAs against GATA-1 or control on day 11 of E culture. Error bars represent standard deviation obtained from three independent experiments. * P < 0.05; ** P < 0.01. ( J ) Q-PCR analysis of Pri-27a∼24, mature miR-27a and miR-24 expression in CD34+ HPCs treated as described in (I). Error bars represent the standard deviation obtained from three independent experiments. ** P < 0.01.
Article Snippet: CD34+ cells were enriched from mononuclear cells through positive immunomagnetic selection (
Techniques: Expressing, Standard Deviation, Western Blot, Functional Assay, Activity Assay, Mutagenesis, Luciferase, Transfection, Construct, Control, Transduction
Journal: Nucleic Acids Research
Article Title: A regulatory circuit comprising GATA1/2 switch and microRNA-27a/24 promotes erythropoiesis
doi: 10.1093/nar/gkt848
Figure Lengend Snippet: A regulatory circuit involving GATA-1, GATA-2 and miR-27a/24 in erythropoiesis. ( A ) A schematic representation of the regulatory circuit comprised GATA-1, GATA-2, miR-27a and miR-24 in erythroid differentiation. ( B , C ) ChIP-PCR and ChIP-q-PCR analysis of GATA-1 and GATA-2 occupancy at the −557 site in K562s transfected with scramble or miRNA mimics and inhibitors (B, r miR-27a and C, miR-24). ( D ) Q-PCR analysis of Pri-27a∼24 abundance in K562s treated as described in (B) and (C). Error bars represent the standard deviation obtained from three independent experiments. * P < 0.05; ** P < 0.01. ( E ) Q-PCR analysis of Pri-27a∼24 abundance in CD34+ HPCs transduced with Lenti-miR-27a/24 or Lenti-GFP control for 11 days. Error bars represent the standard deviation obtained from three independent experiments. * P < 0.05. ( F ) Q-PCR analysis of Pri-27a∼24 abundance in CD34+ HPCs transduced with Zip-miRNA or Zip-GFP for 11 days. Error bars represent the standard deviation obtained from three independent experiments. ** P < 0.01.
Article Snippet: CD34+ cells were enriched from mononuclear cells through positive immunomagnetic selection (
Techniques: Transfection, Standard Deviation, Transduction, Control